High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain

Kazue Hisaoka-Nakashima, Yoshiaki Tomimura, Toshiki Yoshii, Kazuto Ohata, Naoki Takada, Fang Fang Zhang, Yoki Nakamura, Keyue Liu, Hidenori Wake, Masahiro Nishibori, Yoshihiro Nakata, Norimitsu Morioka

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Clinical evidence indicates that major depression is a common comorbidity of chronic pain, including neuropathic pain. However, the cellular basis for chronic pain-mediated major depression remains unclear. High-mobility group box 1 protein (HMGB1) has a key role in innate immune responses and appears to be have a role in mediating diverse disorders, including neuropathic pain and depression. The current study aimed to characterize neuropathic pain-induced changes in affect over time and to determine whether HMGB1 has a role in neuropathic pain-induced changes in affect. Neuropathic pain was induced by partial sciatic nerve ligation (PSNL) in mice. Anxiodepressive-like behaviors in mice were evaluated over 10 weeks, in the social interaction, forced swim, and novelty suppressed feeding tests. Mice developed anxiodepressive-like behavior 6 to 8 weeks after induction of neuropathy. Accompanying anxiodepressive-like behavior, increased HMGB1 protein and microglia activation were observed in frontal cortex at 8 weeks after PSNL. Intracerebroventricular administration of rHMGB1 in naïve mice induced anxiodepressive-like behavior and microglia activation. Blockage of HMGB1 in PSNL mice with glycyrrhizic acid (GZA) or anti-HMGB1 antibody reduced microglia activation and anxiodepressive-like behavior. These results indicate that PSNL-induced anxiodepressive-like behavior is likely mediated by HMGB1. Furthermore, the data indicate that inhibition of HMGB1-dependent microglia activation could be a strategy for the treatment of depression associated with neuropathic pain.

Original languageEnglish
Pages (from-to)347-362
Number of pages16
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume92
DOIs
Publication statusPublished - Jun 8 2019

Fingerprint

HMGB1 Protein
Neuralgia
Microglia
Sciatic Nerve
Ligation
Depression
Chronic Pain
Glycyrrhizic Acid
Frontal Lobe
Interpersonal Relations
Innate Immunity
Comorbidity
Antibodies

Keywords

  • Depression
  • HMGB1
  • Microglia
  • Neuropathic pain

ASJC Scopus subject areas

  • Pharmacology
  • Biological Psychiatry

Cite this

High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain. / Hisaoka-Nakashima, Kazue; Tomimura, Yoshiaki; Yoshii, Toshiki; Ohata, Kazuto; Takada, Naoki; Zhang, Fang Fang; Nakamura, Yoki; Liu, Keyue; Wake, Hidenori; Nishibori, Masahiro; Nakata, Yoshihiro; Morioka, Norimitsu.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 92, 08.06.2019, p. 347-362.

Research output: Contribution to journalArticle

Hisaoka-Nakashima, Kazue ; Tomimura, Yoshiaki ; Yoshii, Toshiki ; Ohata, Kazuto ; Takada, Naoki ; Zhang, Fang Fang ; Nakamura, Yoki ; Liu, Keyue ; Wake, Hidenori ; Nishibori, Masahiro ; Nakata, Yoshihiro ; Morioka, Norimitsu. / High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019 ; Vol. 92. pp. 347-362.
@article{59b7dfe270a8413d9b83dcf074c0272f,
title = "High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain",
abstract = "Clinical evidence indicates that major depression is a common comorbidity of chronic pain, including neuropathic pain. However, the cellular basis for chronic pain-mediated major depression remains unclear. High-mobility group box 1 protein (HMGB1) has a key role in innate immune responses and appears to be have a role in mediating diverse disorders, including neuropathic pain and depression. The current study aimed to characterize neuropathic pain-induced changes in affect over time and to determine whether HMGB1 has a role in neuropathic pain-induced changes in affect. Neuropathic pain was induced by partial sciatic nerve ligation (PSNL) in mice. Anxiodepressive-like behaviors in mice were evaluated over 10 weeks, in the social interaction, forced swim, and novelty suppressed feeding tests. Mice developed anxiodepressive-like behavior 6 to 8 weeks after induction of neuropathy. Accompanying anxiodepressive-like behavior, increased HMGB1 protein and microglia activation were observed in frontal cortex at 8 weeks after PSNL. Intracerebroventricular administration of rHMGB1 in na{\"i}ve mice induced anxiodepressive-like behavior and microglia activation. Blockage of HMGB1 in PSNL mice with glycyrrhizic acid (GZA) or anti-HMGB1 antibody reduced microglia activation and anxiodepressive-like behavior. These results indicate that PSNL-induced anxiodepressive-like behavior is likely mediated by HMGB1. Furthermore, the data indicate that inhibition of HMGB1-dependent microglia activation could be a strategy for the treatment of depression associated with neuropathic pain.",
keywords = "Depression, HMGB1, Microglia, Neuropathic pain",
author = "Kazue Hisaoka-Nakashima and Yoshiaki Tomimura and Toshiki Yoshii and Kazuto Ohata and Naoki Takada and Zhang, {Fang Fang} and Yoki Nakamura and Keyue Liu and Hidenori Wake and Masahiro Nishibori and Yoshihiro Nakata and Norimitsu Morioka",
year = "2019",
month = "6",
day = "8",
doi = "10.1016/j.pnpbp.2019.02.005",
language = "English",
volume = "92",
pages = "347--362",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain

AU - Hisaoka-Nakashima, Kazue

AU - Tomimura, Yoshiaki

AU - Yoshii, Toshiki

AU - Ohata, Kazuto

AU - Takada, Naoki

AU - Zhang, Fang Fang

AU - Nakamura, Yoki

AU - Liu, Keyue

AU - Wake, Hidenori

AU - Nishibori, Masahiro

AU - Nakata, Yoshihiro

AU - Morioka, Norimitsu

PY - 2019/6/8

Y1 - 2019/6/8

N2 - Clinical evidence indicates that major depression is a common comorbidity of chronic pain, including neuropathic pain. However, the cellular basis for chronic pain-mediated major depression remains unclear. High-mobility group box 1 protein (HMGB1) has a key role in innate immune responses and appears to be have a role in mediating diverse disorders, including neuropathic pain and depression. The current study aimed to characterize neuropathic pain-induced changes in affect over time and to determine whether HMGB1 has a role in neuropathic pain-induced changes in affect. Neuropathic pain was induced by partial sciatic nerve ligation (PSNL) in mice. Anxiodepressive-like behaviors in mice were evaluated over 10 weeks, in the social interaction, forced swim, and novelty suppressed feeding tests. Mice developed anxiodepressive-like behavior 6 to 8 weeks after induction of neuropathy. Accompanying anxiodepressive-like behavior, increased HMGB1 protein and microglia activation were observed in frontal cortex at 8 weeks after PSNL. Intracerebroventricular administration of rHMGB1 in naïve mice induced anxiodepressive-like behavior and microglia activation. Blockage of HMGB1 in PSNL mice with glycyrrhizic acid (GZA) or anti-HMGB1 antibody reduced microglia activation and anxiodepressive-like behavior. These results indicate that PSNL-induced anxiodepressive-like behavior is likely mediated by HMGB1. Furthermore, the data indicate that inhibition of HMGB1-dependent microglia activation could be a strategy for the treatment of depression associated with neuropathic pain.

AB - Clinical evidence indicates that major depression is a common comorbidity of chronic pain, including neuropathic pain. However, the cellular basis for chronic pain-mediated major depression remains unclear. High-mobility group box 1 protein (HMGB1) has a key role in innate immune responses and appears to be have a role in mediating diverse disorders, including neuropathic pain and depression. The current study aimed to characterize neuropathic pain-induced changes in affect over time and to determine whether HMGB1 has a role in neuropathic pain-induced changes in affect. Neuropathic pain was induced by partial sciatic nerve ligation (PSNL) in mice. Anxiodepressive-like behaviors in mice were evaluated over 10 weeks, in the social interaction, forced swim, and novelty suppressed feeding tests. Mice developed anxiodepressive-like behavior 6 to 8 weeks after induction of neuropathy. Accompanying anxiodepressive-like behavior, increased HMGB1 protein and microglia activation were observed in frontal cortex at 8 weeks after PSNL. Intracerebroventricular administration of rHMGB1 in naïve mice induced anxiodepressive-like behavior and microglia activation. Blockage of HMGB1 in PSNL mice with glycyrrhizic acid (GZA) or anti-HMGB1 antibody reduced microglia activation and anxiodepressive-like behavior. These results indicate that PSNL-induced anxiodepressive-like behavior is likely mediated by HMGB1. Furthermore, the data indicate that inhibition of HMGB1-dependent microglia activation could be a strategy for the treatment of depression associated with neuropathic pain.

KW - Depression

KW - HMGB1

KW - Microglia

KW - Neuropathic pain

UR - http://www.scopus.com/inward/record.url?scp=85061820083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061820083&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2019.02.005

DO - 10.1016/j.pnpbp.2019.02.005

M3 - Article

C2 - 30763674

AN - SCOPUS:85061820083

VL - 92

SP - 347

EP - 362

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

ER -